Correction to: The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells (Cell Death & Disease, (2013), 4, 9, (e810), 10.1038/cddis.2013.330)

Correction to: Cell Death and Diseasehttps://doi.org/10.1038/cddis.2013.330, published online 19 September 2013 In Figure 4e (Ac-tubulin) and Figure 5b (p-EGFR), the western blots were inadvertently misplaced during final figure preparation. The results have been confirmed by three replicates and the figures have been corrected accordingly. These corrections do not affect the results and conclusions of this study. We deeply apologize for any confusion or inconvenience that this may have caused. The original article has been corrected. The original blots of three replicates for the correction of 4e: (Figure presented.) Corrected figure 4: (Figure presented.) The original blots of three replicates for the correction of 5b: (Figure presented.) Corrected figure 5: (Figure presented.)